News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vaccinex Inc
(NQ:
VCNX
)
6.100
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
6.100
Bid (Size)
6.000 (1)
Ask (Size)
7.000 (2)
Prev. Close
6.100
Today's Range
6.100 - 6.100
52wk Range
0.5115 - 10.10
Shares Outstanding
65,941,086
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
June 06, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 31, 2024
Via
Benzinga
Performance
YTD
+709.23%
+709.23%
1 Month
+12.96%
+12.96%
3 Month
-21.34%
-21.34%
6 Month
+729.93%
+729.93%
1 Year
+16.29%
+16.29%
More News
Read More
VCNX Stock Earnings: Vaccinex Reported Results for Q1 2024
May 16, 2024
Via
InvestorPlace
VCNX Stock Earnings: Vaccinex Reported Results for Q4 2023
April 02, 2024
Via
InvestorPlace
Why Vaccinex (VCNX) Stock Is Trading Lower
February 15, 2024
Via
Benzinga
Why Vaccinex (VCNX) Stock Is Popping Off
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 27, 2024
Via
Benzinga
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 25, 2024
Via
Benzinga
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
April 02, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
March 27, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
February 21, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex, Inc. Announces Reverse Stock Split
February 15, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 09, 2024
Via
Benzinga
Vaccinex Announces Pricing of $3.7 Million PIPE Financing
February 07, 2024
From
Vaccinex, Inc.
Via
GlobeNewswire
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
December 04, 2023
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseases
October 26, 2023
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting
October 31, 2023
From
Vaccinex, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
October 09, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close